| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073 |
| filingDate |
2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffded52a4710d01534b217e182f7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd164ba02cf8d1e459400b2fa44a5a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76fd62f41428fdf44a1ddd237fe6160f |
| publicationDate |
2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180004052-A |
| titleOfInvention |
A use of 5-Hydroxytryptamine receptor 2B and neuropeptide Y as a marker for predicting differentiation of stem cells |
| abstract |
The present invention discloses the use of 5-Hydroxytryptamine receptor 2B (HTR2B) and neuropeptide Y as stem cell differentiation prediction markers, and more specifically, to a stem cell differentiation prediction including a substance for measuring mRNA expression or protein expression of HTR2B gene A method for predicting the differentiation of stem cells using the marker marker composition; Or neuropeptide Y gene mRNA expression or protein expression, and a method for predicting the differentiation of stem cells using the marker composition. The present invention confirms that HTR2B and neuropeptide Y can be used as a stem cell differentiation prediction marker. Thus, it is possible to predict the differentiation into various cardiac cells or neurons in various undifferentiated stem cells, The possibility of using undifferentiated stem cells as a selective cell therapy agent can be provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019313242-A1 |
| priorityDate |
2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |